Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05958368

Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes

The Effects of Hass Avocados on Glycemic Control in Persons With Type 2 Diabetes: A Randomized Controlled Crossover Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
48 (estimated)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to assess the effects of Hass Avocados on glycemic control. The investigators hypothesize that Hass Avocado consumption will reduce fasting blood sugar compared to an isocaloric amount of other fruit during controlled feeding.

Conditions

Interventions

TypeNameDescription
OTHERAvocadoThe Hass Avocado group will consume 7 avocados a week (1 / day; \~240 kcals/d).
OTHEROther Fruit(s)The other fruits group will consume fruit(s) matched to the avocado in energy and form (i.e., solid fruit).

Timeline

Start date
2023-10-10
Primary completion
2026-05-30
Completion
2026-12-15
First posted
2023-07-24
Last updated
2025-07-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05958368. Inclusion in this directory is not an endorsement.

Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes (NCT05958368) · Clinical Trials Directory